Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.

Biotechnology

Education

Seismic Therapeutic

Jo Viney

Melanie Manning

Yi Xing

Ivan Mascanfroni

Daniela Cipolletta

Jyothsna Visweswaraiah

John Sundy

Kevin Otipoby

Edward Freedman

Maude Tessier

Debora Marks

Nathan Higginson-Scott

The executive team at Seismic Therapeutic has a history of experience in the pharmaceutical and healthcare industries. The team includes individuals with experience in business development, strategic initiatives, and licensing from companies such as Merck and Xanthus Pharmaceuticals. The team also has a strong educational background, with members holding degrees from universities such as the University of Toronto and McGill University in fields such as molecular biology and biochemistry.

CEO and Executive Team

Leadership Team

Founding Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Seismic Therapeutic

Leadership Team

Founding Team

Board of Directors